Evonik receives APAC Bioprocessing Excellence Award

Evonik receives APAC Bioprocessing Excellence Award

Evonik selected for high-quality Cell Culture Solutions

  • By ICN Bureau | April 23, 2024

Evonik has been awarded an Asia-Pacific Bioprocessing Excellence Award (ABEA) for the second year running. The company received the award for its Cell Culture Solutions portfolio in the category Best New Bioprocessing Supplier Award: Upstream Processing. Cell culture is a key growth area for Evonik’s Health Care business.

As part of the company’s life sciences division, Nutrition & Care, the Cell Culture Solutions offered by Evonik are a cornerstone to its expanding portfolio of biosolutions. Customers benefit from a tailored offering of ingredients, as well as application and formulation expertise as a system solution. Nutrition & Care aims to increase its share of system solutions to 70 percent by 2032. 

“It is a great honor to be recognized by the Asia-Pacific biopharma community for the second year in a row. We look forward to many more fruitful collaborations with companies in the region and look forward to exceeding their cell culture media and bioprocessing needs,” said Shirley Qi, President Southeast Asia, Australia & New Zealand/head of Nutrition & Care Asia Pacific at Evonik.

The annual Asia-Pacific Biopharma Excellence Awards (ABEA) are organized by the global biopharmaceutical B2B and marketing intelligence company IMAPAC.

“Winning this award is a testament to the efforts of our team to serve the biopharma community. Our success further encourages us to develop more innovative solutions to solve bioprocessing challenges with our cell culture solutions portfolio,” said Spandan Mishra, Associate Director Business Development – Biopharma Solutions at Evonik Health Care for Asia Pacific.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories